Question 1

What is DPM3-congenital disorder of glycosylation?

Accepted Answer

DPM3-congenital disorder of glycosylation (DPM3-CDG) is an extremely rare type of congenital disorder of glycosylation. This group of conditions affects how glycoproteins are made, which are important for many body functions. In the single reported case, people with this condition showed signs like muscle weakness and abnormalities in walking.

In addition to issues with muscle function, there was also involvement of the heart, specifically dilated cardiomyopathy. Because only one case has been reported so far, our understanding of this condition is still very limited.

Question 2

What are the symptoms of DPM3-congenital disorder of glycosylation?

Accepted Answer

People with DPM3-CDG may experience muscle weakness and a waddling gait. In the reported case, there was also dilated cardiomyopathy, which means the heart's ability to pump blood can be compromised.

Question 3

What causes DPM3-congenital disorder of glycosylation?

Accepted Answer

DPM3-CDG is caused by changes in the DPM3 gene. These genetic changes likely lead to problems with the process of glycosylation, which is important in making glycoproteins. This disruption may result in the muscle and heart issues noted in the reported case. Associated genes include DPM3.

Question 4

How is DPM3-congenital disorder of glycosylation inherited?

Accepted Answer

DPM3-congenital disorder of glycosylation follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is DPM3-congenital disorder of glycosylation?

Accepted Answer

DPM3-congenital disorder of glycosylation is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is DPM3-congenital disorder of glycosylation diagnosed?

Accepted Answer

Information about diagnosis is currently limited for this condition.

Question 7

Are there treatments for DPM3-congenital disorder of glycosylation?

Accepted Answer

Information about treatment is currently limited for this condition.

Question 8

What complications can arise from DPM3-congenital disorder of glycosylation?

Accepted Answer

DPM3-congenital disorder of glycosylation can lead to muscle weakness and a waddling gait. Additionally, there may be serious heart issues, such as dilated cardiomyopathy, which affects how well the heart pumps blood. Since only one case has been reported, we don't know all the possible complications yet.

Question 9

How does DPM3-congenital disorder of glycosylation affect daily life?

Accepted Answer

Living with DPM3-congenital disorder of glycosylation may involve challenges like muscle weakness that can make movement difficult. This could affect daily activities, such as walking or playing. Families may need to find ways to support mobility and manage any heart-related issues.

Question 10

What is the prognosis for someone with DPM3-congenital disorder of glycosylation?

Accepted Answer

Currently, information about the prognosis for DPM3-congenital disorder of glycosylation is very limited. Since only one case has been reported, we don't have enough data to predict how the condition may progress or what the long-term outcomes might be. Ongoing research may provide more insights in the future.

Question 11

Are there any specialists that should be involved in managing DPM3-congenital disorder of glycosylation?

Accepted Answer

For someone with DPM3-congenital disorder of glycosylation, it may be helpful to work with specialists such as a geneticist and a cardiologist. A geneticist can help understand the genetic aspects of the condition, while a cardiologist can monitor and manage any heart issues. Since this is a rare condition, a team approach may be beneficial.

Organ System	Phenotype Count	Example Features
Muscles	10	Myopathy, Gowers sign, Limb-girdle muscular dystrophy
Brain and nerves	5	Waddling gait, Unsteady gait, Profound intellectual disability
Lab test results	3	Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Elevated circulating hepatic transaminase concentration, Elevated creatine kinase after exercise
Heart and blood vessels	3	Enlarged and weakened heart (dilated cardiomyopathy), Stroke-like episode, Chest pain
Arms and legs	1	Limb-girdle muscular dystrophy
Digestive system	1	Elevated circulating hepatic transaminase concentration

Research Type	Count	% of Total
Research summaries	88	43%
Laboratory research	84	41%
Testing and diagnosis research	13	6%
Disease patterns and progression	11	5%
Patient case studies	5	2%
New treatment approaches	3	1%
Other research	2	1%

Kisho

DPM3-congenital disorder of glycosylation

Overview

Clinical Presentation

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

DPM3-congenital disorder of glycosylation

Overview

Clinical Presentation

Medical References

External Resources

OMIM

Orphanet

GARD

Subtypes

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is DPM3-congenital disorder of glycosylation?

What are the symptoms of DPM3-congenital disorder of glycosylation?

What causes DPM3-congenital disorder of glycosylation?

How is DPM3-congenital disorder of glycosylation inherited?

How rare is DPM3-congenital disorder of glycosylation?

How is DPM3-congenital disorder of glycosylation diagnosed?

Are there treatments for DPM3-congenital disorder of glycosylation?

What complications can arise from DPM3-congenital disorder of glycosylation?

How does DPM3-congenital disorder of glycosylation affect daily life?

What is the prognosis for someone with DPM3-congenital disorder of glycosylation?

Are there any specialists that should be involved in managing DPM3-congenital disorder of glycosylation?

Explore clinical features

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications